Skip to content

CVC Unplugged

  • Global Corporate Venturing
  • Global University Venturing
  • Global Corporate Venturing
  • Global University Venturing

Home » 11 December 2017 – Obsidian Therapeutics Raises $49.5m

December 11, 2017Podcast

11 December 2017 – Obsidian Therapeutics Raises $49.5m

http://media.blubrry.com/globalventuringreview/dev.globalventuringreview.com/wp-content/uploads/2017/12/89-globalventuringreview-11dec2017.mp3

Podcast: Play in new window | Download (Duration: 20:17 — 18.7MB) | Embed

Subscribe: RSS

Covering the week’s venturing news including funding, investments, exits and people moves. This week’s episode includes: Fund news from Viola and GeneChem and deal news from Neon Therapeutics and Obsidian Therapeutics, plus much more.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Tagged with: "Neon Therapeutics""Obsidian Therapeutics"corporate venturingfundingGeneChemgovernment venturinginvestmentIPOuniversity venturingventure capitalViola

← Older04 December 2017 – Europe ‘Guarantees’ Research & Innovation Budget
Newer →18 December 2017 – OneWeb Follows SpaceX with a $500m Investment

Recent Posts

  • Mario Augusto Maia: Cogent Venture Partners
  • Jeffrey Grabow: EY
  • Dina Routhier & Michael Mahan – Stanley Ventures
  • Erin VanLanduit: Cargill Ventures
  • Raj Singh: JLL Spark Global Ventures

Categories

  • Podcast

Copyright © 2025 CVC Unplugged. Powered by Podcast+